«With the rise of new and
unproven stem cell treatments, the NFL faces a daunting task of trying to better understand and
regulate the use of these
therapies in order to protect the health of its players,» said Kirstin Matthews, the Baker Institute fellow in science and technology policy and an expert on ethical and policy issues related to biomedical research and development.